1. Home
  2. FATE vs SORA Comparison

FATE vs SORA Comparison

Compare FATE & SORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • SORA
  • Stock Information
  • Founded
  • FATE 2007
  • SORA 2001
  • Country
  • FATE United States
  • SORA Hong Kong
  • Employees
  • FATE N/A
  • SORA N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • SORA Other Specialty Stores
  • Sector
  • FATE Health Care
  • SORA Industrials
  • Exchange
  • FATE Nasdaq
  • SORA Nasdaq
  • Market Cap
  • FATE 116.5M
  • SORA 111.9M
  • IPO Year
  • FATE 2013
  • SORA 2025
  • Fundamental
  • Price
  • FATE $1.47
  • SORA $5.01
  • Analyst Decision
  • FATE Hold
  • SORA
  • Analyst Count
  • FATE 6
  • SORA 0
  • Target Price
  • FATE $3.30
  • SORA N/A
  • AVG Volume (30 Days)
  • FATE 3.1M
  • SORA 31.4K
  • Earning Date
  • FATE 11-11-2025
  • SORA 01-01-0001
  • Dividend Yield
  • FATE N/A
  • SORA N/A
  • EPS Growth
  • FATE N/A
  • SORA N/A
  • EPS
  • FATE N/A
  • SORA N/A
  • Revenue
  • FATE $8,470,000.00
  • SORA $17,619,363.00
  • Revenue This Year
  • FATE N/A
  • SORA N/A
  • Revenue Next Year
  • FATE N/A
  • SORA N/A
  • P/E Ratio
  • FATE N/A
  • SORA N/A
  • Revenue Growth
  • FATE N/A
  • SORA N/A
  • 52 Week Low
  • FATE $0.66
  • SORA $3.19
  • 52 Week High
  • FATE $3.50
  • SORA $14.15
  • Technical
  • Relative Strength Index (RSI)
  • FATE 62.81
  • SORA N/A
  • Support Level
  • FATE $1.30
  • SORA N/A
  • Resistance Level
  • FATE $1.65
  • SORA N/A
  • Average True Range (ATR)
  • FATE 0.17
  • SORA 0.00
  • MACD
  • FATE 0.02
  • SORA 0.00
  • Stochastic Oscillator
  • FATE 73.77
  • SORA 0.00

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About SORA Top Win International Limited Ordinary Shares

AsiaStrategy is a wholesaler engaged in trading, distribution, and retail of luxury watches of international brands. The Group sources its luxury watches from Europe, Singapore, Japan, and Hong Kong, then sells the goods to retail sellers and other distributors in the watch industry.

Share on Social Networks: